Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Claudepierre

Showing results (71-80 of 154) with videos related to

Pageof 16
Sort By:
Clinical and Experimental Rheumatology|January 9, 2019
Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohortValerie Nadon, Anna Moltó, Adrien Etcheto, et al.
RMD Open|March 18, 2022
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in FranceMaxime Dougados, Julien Lucas, Emilie Desfleurs, et al.
The Journal of Rheumatology|March 11, 2009
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitisMartin Rudwaleit, Pascal Claudepierre, Paul Wordsworth, et al.
RMD Open|March 15, 2023
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)Maxime Dougados, Julien Lucas, Emilie Desfleurs, et al.
The Journal of Rheumatology|December 17, 2003
Lymphocytic infiltration and expression of inducible nitric oxide synthase in human duodenal and colonic mucosa is a characteristic feature of ankylosing spondylitisDominique Lamarque, Jeanne Tran Van Nhieu, Maxime Breban, et al.
Seminars in Arthritis and Rheumatism|June 1, 2023
Bone marrow edema in the sacroiliac joints is associated with the development of structural lesions at the same anatomical location over time in patients with axial spondyloarthritisSantiago Rodrigues-Manica, Alexandre Sepriano, Sofia Ramiro, et al.
RMD Open|March 1, 2024
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA studyMaxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2014
Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohortRosaline van den Berg, Grégory Lenczner, Antoine Feydy, et al.
RMD Open|May 13, 2020
5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohortQueeny Madari, Alexandre Sepriano, Sofia Ramiro, et al.
Joint Bone Spine|March 8, 2022
Systematic assessment of heart valves and cardiac function by echocardiography in axial spondyloarthritis: A systematic review and meta-analysisXavier Romand, Fanny Adeline, Mickael Dalecky, et al.
Pageof 16

Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Clinical and Experimental Rheumatology|January 9, 2019
Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohortValerie Nadon, Anna Moltó, Adrien Etcheto, et al.
RMD Open|March 18, 2022
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in FranceMaxime Dougados, Julien Lucas, Emilie Desfleurs, et al.
The Journal of Rheumatology|March 11, 2009
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitisMartin Rudwaleit, Pascal Claudepierre, Paul Wordsworth, et al.
RMD Open|March 15, 2023
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)Maxime Dougados, Julien Lucas, Emilie Desfleurs, et al.
The Journal of Rheumatology|December 17, 2003
Lymphocytic infiltration and expression of inducible nitric oxide synthase in human duodenal and colonic mucosa is a characteristic feature of ankylosing spondylitisDominique Lamarque, Jeanne Tran Van Nhieu, Maxime Breban, et al.
Seminars in Arthritis and Rheumatism|June 1, 2023
Bone marrow edema in the sacroiliac joints is associated with the development of structural lesions at the same anatomical location over time in patients with axial spondyloarthritisSantiago Rodrigues-Manica, Alexandre Sepriano, Sofia Ramiro, et al.
RMD Open|March 1, 2024
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA studyMaxime Dougados, Audrey Lardy-Cléaud, Emilie Desfleurs, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 10, 2014
Agreement between clinical practice and trained central reading in reading of sacroiliac joints on plain pelvic radiographs. Results from the DESIR cohortRosaline van den Berg, Grégory Lenczner, Antoine Feydy, et al.
RMD Open|May 13, 2020
5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohortQueeny Madari, Alexandre Sepriano, Sofia Ramiro, et al.
Joint Bone Spine|March 8, 2022
Systematic assessment of heart valves and cardiac function by echocardiography in axial spondyloarthritis: A systematic review and meta-analysisXavier Romand, Fanny Adeline, Mickael Dalecky, et al.
Pageof 16